Modulation of the Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination by Nonsteroidal Anti-Inflammatory Drugs

Evidence is scarce to guide the use of nonsteroidal anti-inflammatory drugs (NSAIDs) to mitigate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine–related adverse effects, given the possibility of blunting the desired immune response. In this pilot study, we deeply phenotyped a sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Skarke, Carsten, Lordan, Ronan, Barekat, Kayla, Naik, Amruta, Mathew, Divij, Ohtani, Takuya, Greenplate, Allison R., Grant, Gregory R., Lahens, Nicholas F., Gouma, Sigrid, Troisi, Elizabeth, Sengupta, Arjun, Weljie, Aalim M., Meng, Wenzhao, Luning Prak, Eline T., Lundgreen, Kendall, Bates, Paul, Meng, Hu, FitzGerald, Garret A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2023
Materias:
Special Section on Clinical Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353078/
https://www.ncbi.nlm.nih.gov/pubmed/37105582
http://dx.doi.org/10.1124/jpet.122.001415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353078/
https://www.ncbi.nlm.nih.gov/pubmed/37105582
http://dx.doi.org/10.1124/jpet.122.001415

Ejemplares similares